옵션 체인은 다양한 행사가격과 만기일에 대한 LYTUS TECHNOLOGIES HLDGS PTV LTD SHS NEW COM 60:1의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 LYTUS TECHNOLOGIES HLDGS PTV LTD SHS NEW COM 60:1에 대한 시장 심리를 평가합니다..

LYTUS TECHNOLOGIES HLDGS PTV LTD SHS NEW COM 60:1 (NASDAQ:LYT) 주식, 옵션 체인

Lytus Technologies Hldgs

LYTUS TECHNOLOGIES HLDGS PTV LTD SHS NEW COM 60:1

LYTUS TECHS HLDGS PTV LTD by Lytus Technologies Holdings PTV. Ltd.

Lytus Technologies Holdings Pvt Ltd

LSI Industries Inc

Piper Sandler analyst Matthew Clark maintains HomeStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HMST#NASDAQ">HMST</a>) with a Neutral and raises the price target from $10 to $14.

News

Price Target

Analyst Ratings

HMST

Piper Sandler Maintains Neutral on HomeStreet, Raises Price Target to $14

Macro Economic Events

Economics

White House Says If You Make In America, You Will Pay No Tariffs; White House Spokesperson, Asked On Tariffs, Says President Is Always Open To Taking Calls; President Is With Trade And Tariff Team Now

Goldman Sachs analyst Chris Shibutani maintains Vaxcyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) with a Buy and lowers the price target from $138 to $100.

PCVX

Goldman Sachs Maintains Buy on Vaxcyte, Lowers Price Target to $100

White House Says Reciprocal Tariffs Will Take Effect Immediately; The Market Is A Snapshot In Time; Wall Street Will Be Just Fine;  There Are A Few Countries Who Have Called To Discuss Tariffs

For better or for worse, Q1 of 2025 has been an active period for cannabis legislation in Georgia. After years on the backburner, cannabis has finally become a focal point for Georgia lawmakers. Early last month, the Georgia Senate passed three bills effecting Georgians' access to hemp and medical cannabis prior to Georgia's 2025 crossover day, which is the deadline for legislation to pass out of at least one chamber to remain alive in the legislative session set to end on April 4, 2025. 
Two of these bills, Senate Bill 254 and Senate Bill 33, are aimed at restricting access to recreational hemp products containing tetrahydrocannabinol (THC), the main psychoactive ingredient found in the cannabis plant, responsible for producing the "high effect" &#8212; while, the third bill, Senate Bill 220, would expand access to medical patients seeking treatment through Georgia's "Low THC Oil Registry." This registry allows physicians to certify and manage patients who have a "qualifying condition" to obtain Low THC Oil legally. 
Starting with the first two pieces of legislation, SB 254 and SB 33 would limit what is legally available at retail shops<a> </a>statewide by restricting the legal potency of all consumable hemp products, including gummies and tinctures, as well as imposing a complete ban of all THC-infused hemp beverages pursuant to SB 254. Georgia Republican senator, Bill Cowsert of Athens, who helped win passage of SB 254 banning all THC-infused drinks, stated the following regarding its passage:
"This is for public safety. You may hear other people speak on this, but these current ten-milligram beverages are like four shots of liquor, or four glasses of wine, or four beers &#8211; all in one can. So we are putting loaded guns in people's hands in the form of a can, or a gummy. We need to protect them and keep them away from children. We need to make sure people are responsible in the use of these products."
Additionally, SB 33 would introduce strict testing and labeling requirements for cannabinoids such as delta-8 THC, delta-10 THC, and hexahydrocannabinol (HHC). All of which could be traditionally found in gas stations, convenience stores, and smoke shops across the state. Granted, the passage of these bills would effectively stifle consumer access and devastate Georgia's hemp market, as retailers and processors face new regulatory requirements and risk of noncompliance.
Meanwhile, SB 220, otherwise known as the &#8220;Putting Georgia&#8217;s Patients First Act,&#8221; would expand access to medical cannabis by adding Lupus to the list of qualifying conditions and removing language requiring many of the qualifying ailments to either be terminal or late-stage. Additionally, the bill would allow for inhalation, although raw flower would continue to be banned as well as a 50% cap on THC levels.&nbsp;Furthermore, SB 220 would allow for reciprocity for medical cannabis cardholders of other states on a temporary basis. Such measure would allow for out-of-staters who may not qualify under Georgia's medical registry to access Georgia medical cannabis, despite not potentially meeting Georgia's qualifying aliments. &nbsp;
While the Senate's passing of SB 220 can be seen as an early win for those who qualify, and their loved ones, the simultaneous passing of SB 254 and SB 33 may appear to raise more questions than answers – especially for the majority of Georgia voters who believe adult-use should be legal. Perhaps the expansion of Georgia's medical cannabis program will serve as the first and long-awaited step of many to demystifying cannabis in the Peach State.

Cannabis

Opinion

General

Georgia Cannabis On Lawmakers' Minds

WIIM

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

Orchestra BioMed shares are trading lower after the company reported a FY24 sales miss.

Zeta Global Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) short percent of float has fallen 15.35% since its last report. The company recently reported that it has 22.78 million shares sold short, which is 12.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.1 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Zeta Global Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743525926_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Zeta Global Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Zeta Global Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Zeta Global Holdings's peer group average for short interest as a percentage of float is 12.13%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

ZETA

Is the Market Bullish or Bearish on Zeta Global Holdings?

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 20 years by 1.21% on an annualized basis producing an average annual return of 9.32%. Currently, Carpenter Tech has a market capitalization of $9.05 billion. 
Buying $100 In CRS: If an investor had bought $100 of CRS stock 20 years ago, it would be worth $580.61 today based on a price of $181.18 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743525925_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Carpenter Tech Stock In The Last 20 Years

Domino's Pizza's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) short percent of float has fallen 6.25% since its last report. The company recently reported that it has 1.73 million shares sold short, which is 5.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Domino's Pizza Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743525920_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Domino's Pizza has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Domino's Pizza's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Domino's Pizza's peer group average for short interest as a percentage of float is 10.44%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Domino's Pizza?

AARD

Aardvark Therapeutics shares are trading higher after RBC Capital and Cantor Fitzgerald reiterated their respective ratings on the stock and maintained their price targets.

AstraZeneca's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NYSE">AZN</a>) short percent of float has fallen 10.91% since its last report. The company recently reported that it has 15.24 million shares sold short, which is 0.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AstraZeneca Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743525915_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AstraZeneca has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AstraZeneca's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AstraZeneca's peer group average for short interest as a percentage of float is 4.23%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into AstraZeneca's Recent Short Interest

Goldman Sachs analyst Alex Scott maintains American International Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) with a Neutral and raises the price target from $79 to $87.

Goldman Sachs Maintains Neutral on American International Gr, Raises Price Target to $87

ELVA

Electrovaya shares are trading higher after the company announced it receivesd a $8.7 million order from fortune 500 customer to power distribution centers.

Fartcoin (CRYPTO: FARTCOIN) is up 19% on the day, with traders pointing out that the popular meme coin is acting as a <a href="https://www.benzinga.com/money/bitcoin-price-prediction">high-beta play on Bitcoin</a>. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>24-Hour Trend</td>
</tr>
<tr>
<td>Fartcoin (CRYPTO: FARTCOIN)</td>
<td> $0.52</td>
<td> +19%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.1736</td>
<td> +3.8%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00001293</td>
<td> +3.2%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader CRG noted that Fartcoin's chart is showing strength.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fartcoin looking good here <a href="https://t.co/1L19VoOmbZ">https://t.co/1L19VoOmbZ</a> <a href="https://t.co/XUBj4QjH75">pic.twitter.com/XUBj4QjH75</a>
&mdash; CRG (@MacroCRG) <a href="https://twitter.com/MacroCRG/status/1907003805033501061?ref_src=twsrc%5Etfw">April 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Altcoin Sherpa <a href="https://x.com/AltcoinSherpa/status/1907018789033550216">pointed </a>out a higher-low formation on the 4-hour chart, although the daily chart still "looks pretty ugly." 
He also <a href="https://x.com/AltcoinSherpa/status/1907021694348517715">believes</a> that if the market turns bullish, Fartcoin will remain the &#8220;strongest beta&#8221; relative to Bitcoin. 
If BTC moves 2% higher, Fartcoin will rally 5%-20%, the trader predicts.
Another trader <a href="https://x.com/astekz/status/1907014161655120177">sees</a> the $0.55-$0.58 range as the breakout level—if Fartcoin clears it, "the real fun begins."
One pseudonymous trader <a href="https://x.com/Xeer/status/1906991937976218025">shared</a> a cautionary tale, revealing losses exceeding $3 million from attempting to buy dips in Fartcoin and other meme coins. 
He admitted that despite leveraging $35,000 to recover, the market's manipulative nature led to further losses, ultimately wiping out everything he had built over 1.5 years in just three months. 
He emphasized that success in crypto isn't just about skill—it requires size, insider knowledge and patience.
Statistics: Stalkchain <a href="https://x.com/StalkHQ/status/1906843961387516239">data</a> shows Fartcoin as the most purchased token by smart money in the last 24 hours. Fartcoin ranked 5th in meme coin trading volume with $184.6 million, signaling strong trader interest.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44516481/can-fartcoin-beat-dogecoin-shiba-inu-to-become-the-biggest-winner-this-year">Can Fartcoin Beat Dogecoin, Shiba Inu To Become The &#8216;Biggest Winner This Year&#8217;?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$SHIB

Fartcoin Leaves Dogecoin, Shiba Inu In The Dust With 19% Rally: 'The Strongest Beta To Bitcoin,' Trader Says

Needham analyst Serge Belanger reiterates Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) from Hold to Hold.

Reiteration

OMER

Needham Reiterates Hold on Omerosto Hold

Canopy Growth shares are trading higher after the company announced it saved $13M annually after making an $100M early loan prepayment.

Goldman Sachs analyst Ryan Nash maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Buy and raises the price target from $45 to $50.

ALLY

Goldman Sachs Maintains Buy on Ally Financial, Raises Price Target to $50

RSLS

ReShape Lifesciences Shares Resumed Trade

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Connect Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) with a Buy and maintains $8 price target.

CNTB

HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $8 Price Target

ELTX

Elicio Therapeutics shares are trading lower after the company reported a FY24 GAAP EPS miss.

Press Releases

Lytus Technologies  enters the audio entertainment sector with the launch of Radio Room, India's first regional Audio OTT platform

Lytus Technologies  Expands Its Footprint into Healthcare with Cutting-Edge Patient-Centric HealthTech Platform

Lytus Technologies Expands HealthTech Initiatives and Strengthens Growth Trajectory

"Technology Stocks to Watch: CSDX, LYT, SINT, TRNR, RSLS, CYCU, TRUG Market Momentum Building"

UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside

Comments

LYTUS TECHNOLOGIES HLDGS PTV LTD SHS NEW COM 60:1

LYTUS TECHNOLOGIES HLDGS PTV LTD SHS NEW COM 60:1 (LYT) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌